Evotec Enters iPSC-based Drug Discovery Partnership with Boehringer Ingelheim in OphthalmologyAccesswire • 01/25/22
Evotec Expands Neuroscience Collaboration with Bristol Myers Squibb to Include New Targeted Protein Degradation ApproachAccesswire • 01/11/22
EQRx and Evotec Announce Integrated Drug Discovery and Development PartnershipBusiness Wire • 11/18/21
Evotec SE (EVOTF) CEO Werner Lanthaler on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/11/21
Evotec SE Reports Results for the First Nine Months 2021 and Provides Corporate UpdateAccesswire • 11/11/21
Evotec Reaches Programme Designations in Neuroscience Collaboration with Bristol Myers SquibbAccesswire • 11/10/21
Evotec SE Announces Placement of Its Public Offering of American Depositary SharesAccesswire • 11/04/21
Evotec SE To Announce Results for the First Nine Months 2021 On 11 November 2021Accesswire • 11/03/21
Pasithea Therapeutics Corp. and Evotec SE Enter into Drug Development AgreementGlobeNewsWire • 10/11/21
Evotec SE files Registration Statement for Proposed Offering of American Depositary SharesAccesswire • 10/11/21
Awakn Life Sciences Initiates New Chemical Entity Development Program with Evotec as Research Partner and Addiction Expert, Prof. David Nutt, as Program LeadNewsfile Corp • 04/27/21
Evotec Partners with Alloy Therapeutics to Expand its Antibody Discovery PlatformAccesswire • 12/21/20